BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32558959)

  • 1. Nasopharyngeal Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma families: Familial aggregation and host heritability.
    Zheng MQ; Wang TM; Liao Y; Xue WQ; He YQ; Wu ZY; Yang DW; Li DH; Deng CM; Jia YJ; Yuan LL; Zhang WL; Luo LT; Tong XT; Wu YX; Zhou T; Li XZ; Tang LL; Zhang JB; Xia YF; Mu J; Jia WH
    J Med Virol; 2020 Dec; 92(12):3717-3725. PubMed ID: 32558959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma.
    Wong KW; Hui KF; Lam KP; Kwong DL; Lung ML; Yang W; Chiang AKS
    PLoS Pathog; 2024 May; 20(5):e1012263. PubMed ID: 38805547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation.
    Xu M; Feng R; Liu Z; Zhou X; Chen Y; Cao Y; Valeri L; Li Z; Liu Z; Cao SM; Liu Q; Xie SH; Chang ET; Jia WH; Shen J; Yao Y; Cai YL; Zheng Y; Zhang Z; Huang G; Ernberg I; Tang M; Ye W; Adami HO; Zeng YX; Lin X
    Cell Genom; 2024 Feb; 4(2):100474. PubMed ID: 38359790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis.
    Zhang J; Shu C; Song Y; Li Q; Huang J; Ma X
    Medicine (Baltimore); 2016 Oct; 95(40):e5130. PubMed ID: 27749596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
    Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
    Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VLDL and LDL Subfractions Enhance the Risk Stratification of Individuals Who Underwent Epstein-Barr Virus-Based Screening for Nasopharyngeal Carcinoma: A Multicenter Cohort Study.
    Zhou Z; Tang T; Li N; Zheng Q; Xiao T; Tian Y; Sun J; Zhang L; Wang X; Wang Y; Ye F; Chen Z; Zhang H; Zheng X; Cai Z; Liu L; Guan J
    Adv Sci (Weinh); 2024 Jun; 11(22):e2308765. PubMed ID: 38520712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.
    Pickard A; Chen CJ; Diehl SR; Liu MY; Cheng YJ; Hsu WL; Sun B; Hsu MM; Chen IH; Chen JY; Yang CS; Mittl BL; Chou SP; Ruggles DD; Goldstein AM; Hildesheim A
    Int J Cancer; 2004 Aug; 111(1):117-23. PubMed ID: 15185352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
    Baizig NM; Morand P; Seigneurin JM; Boussen H; Fourati A; Gritli S; Oueslati Z; Touati S; Gamoudi A; Ben Abdallah M; El May M; El May A
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1005-11. PubMed ID: 21805179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary nasopharyngeal carcinoma with Sjögren's syndrome and positive cerebrospinal fluid Epstein-Barr virus: a case report and literature review].
    Wang S; Qiu F; Zhang HL; Zhao J; Feng JL
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):490-494. PubMed ID: 38715487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of Epstein-Barr virus in familial nasopharyngeal carcinoma.
    Zhang WL; Zhang JB; Wang TM; Wu YX; He YQ; Xue WQ; Liao Y; Deng CM; Li DH; Wu ZY; Yang DW; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Jia WH
    J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35349400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
    Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Zheng XH; Li XZ; Zhou T; Jiang CT; Tang CL; Deng CM; Liao Y; He YQ; Wang TM; Jia WH
    Int J Cancer; 2023 Jun; 152(12):2629-2638. PubMed ID: 36878711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Yu KJ; Hsu WL; Chiang CJ; Chen TC; Liu Z; Lou PJ; Diehl S; Goldstein AM; Chen CJ; Wang CP; Hildesheim A
    Cancer; 2021 Nov; 127(22):4171-4176. PubMed ID: 34324707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
    Chow JCH; Lee AWM; Wong CHL; Ng WT; Liu Z; Tay JK; Loh KS; Pace-Asciak P; Cohen O; Corry J; Rodrigo JP; Tsang RKY; Lopez F; Saba NF; de Bree R; Ferlito A
    Oral Oncol; 2022 Oct; 133():106031. PubMed ID: 35908365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma.
    Liao Y; Zhang JB; Lu LX; Jia YJ; Zheng MQ; Debelius JW; He YQ; Wang TM; Deng CM; Tong XT; Xue WQ; Cao LJ; Wu ZY; Yang DW; Zheng XH; Li XZ; Wu YX; Feng L; Ye W; Mu J; Jia WH
    Microbiol Spectr; 2023 Feb; 11(1):e0344822. PubMed ID: 36645283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.
    Coghill AE; Hsu WL; Yang Q; Wang CP; Lou PJ; Yu KJ; Yu G; Diehl SR; Chen CJ; Goldstein AM; Hildesheim A
    J Gen Virol; 2018 Sep; 99(9):1268-1273. PubMed ID: 29975184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
    Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.